These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8288497)

  • 1. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.
    Pörnull KJ; Göransson E; Rytting AS; Dornbusch K
    J Antimicrob Chemother; 1993 Oct; 32(4):559-70. PubMed ID: 8288497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime.
    Wu SW; Dornbusch K; Göransson E; Ransjö U; Kronvall G
    J Antimicrob Chemother; 1991 Sep; 28(3):389-97. PubMed ID: 1960120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family.
    Wu SW; Dornbusch K; Norgren M; Kronvall G
    J Antimicrob Chemother; 1992 Jul; 30(1):3-16. PubMed ID: 1429334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
    Vercauteren E; Descheemaeker P; Ieven M; Sanders CC; Goossens H
    J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
    Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
    Papanicolaou GA; Medeiros AA; Jacoby GA
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.
    Vatopoulos AC; Philippon A; Tzouvelekis LS; Komninou Z; Legakis NJ
    J Antimicrob Chemother; 1990 Nov; 26(5):635-48. PubMed ID: 2079446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
    Oksüz L; Gürler N
    Mikrobiyol Bul; 2009 Apr; 43(2):183-94. PubMed ID: 19621602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzymatic resistance to cefotaxime in 56 strains of Klebsiella spp., Escherichia coli and Salmonella spp. at a Tunisian hospital (1984-1988)].
    Ben Hassen A; Fournier G; Kechrid A; Fendri C; Ben Redjeb S; Philippon A
    Pathol Biol (Paris); 1990 May; 38(5):464-9. PubMed ID: 2195457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
    Ekşi F; Ozer G; Balci I
    Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
    Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland.
    Woodford N; Reddy S; Fagan EJ; Hill RL; Hopkins KL; Kaufmann ME; Kistler J; Palepou MF; Pike R; Ward ME; Cheesbrough J; Livermore DM
    J Antimicrob Chemother; 2007 Jan; 59(1):102-5. PubMed ID: 17110393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.
    Rasheed JK; Jay C; Metchock B; Berkowitz F; Weigel L; Crellin J; Steward C; Hill B; Medeiros AA; Tenover FC
    Antimicrob Agents Chemother; 1997 Mar; 41(3):647-53. PubMed ID: 9056008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime.
    Arlet G; Rouveau M; Bengoufa D; Nicolas MH; Philippon A
    FEMS Microbiol Lett; 1991 Jun; 65(1):57-62. PubMed ID: 1874404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.